v3.25.4
Pay vs Performance Disclosure
12 Months Ended
Dec. 31, 2025
USD ($)
$ / shares
Dec. 31, 2024
USD ($)
$ / shares
Dec. 31, 2023
USD ($)
$ / shares
Dec. 31, 2022
USD ($)
$ / shares
Dec. 31, 2021
USD ($)
$ / shares
Nov. 01, 2025
$ / shares
Aug. 01, 2025
$ / shares
Apr. 30, 2025
$ / shares
Nov. 05, 2024
$ / shares
Oct. 27, 2024
$ / shares
Aug. 03, 2024
$ / shares
Aug. 01, 2024
$ / shares
Oct. 29, 2023
$ / shares
Aug. 01, 2023
$ / shares
Jul. 28, 2023
$ / shares
Jul. 30, 2022
$ / shares
Jul. 30, 2021
$ / shares
Pay vs Performance Disclosure                                  
Pay vs Performance Disclosure, Table
The following table summarizes the executive compensation earned by the Company’s PEOs and other NEOs, the executive compensation actually paid to the Company’s PEOs and other NEOs, and certain financial performance measures of the Company for the years ended December 31, 2025, 2024, and 2023.
Value of Initial
Fixed $100
Investment
Based On:
Summary Compensation
Table Total for PEO
($)
Compensation Actually
Paid to PEO
($)
Average
Summary
Compensation
Table Total
for non-PEO
NEOs
($)
Average
Compensation
Actually Paid
to non-PEO
NEOs
($)
Total
Share-
holder
Return
($)
Peer
Group
Total
Share-
holder
Return
($)
Net Income
(in
millions)
($)
(2)
EPS
($)
Year(1)
David S.
Chernow
Thomas P.
Mullin
David S.
Chernow
Thomas P.
Mullin
2025
6,542,405 3,042,527 5,332,323 2,321,859 4,061,009 3,303,809 114.38 109.97 214.53 1.16
2024
10,311,733 14,646,553 6,334,427 8,295,239 142.80 92.81 296.70 1.66
2023
10,706,265 10,337,769 6,052,815 5,838,396 93.35 91.50 299.73 1.91
2022
8,780,479 5,558,979 5,868,199 3,774,224 95.17 87.48 198.03 1.23
2021
11,687,600 13,453,100 7,846,358 8,993,933 108.51 109.45 499.95 2.98
(1)
The PEOs were David Chernow and Thomas Mullin for 2025. The non-PEO NEOs were Robert Ortenzio, Michael Malatesta, Martin Jackson, and John Saich for 2025. The PEO was David Chernow for 2024, 2023, 2022, and 2021. The non-PEO NEOs were Robert Ortenzio, Michael Malatesta, Martin Jackson, and Thomas Mullin for 2024. The non-PEO NEOs were Robert Ortenzio, Rocco Ortenzio, Martin Jackson, Michael Malatesta, and Michael Tarvin for 2023. The non-PEO NEOs were Robert Ortenzio, Rocco Ortenzio, Martin Jackson and Michael Tarvin for 2022 and 2021.
(2)
Net income includes earnings attributable to both controlling and non-controlling interests.
The following table outlines the adjustments made to the compensation earned by the Company’s PEOs and other NEOs, as presented in the Summary Compensation Table on page 22, to derive the compensation actually paid to the Company’s PEOs and other NEOs.
Year(1)
Summary
Compensation
Table Total
($)
Adjustments
Compensation
Actually Paid
($)
Less: Reported
Value of
Stock Awards
($)
(2)
Plus: Year End
Fair Value of
Restricted Stock
Awards Granted
During the Year
($)
(3)(4)
Plus: Change in
Fair Value of
Outstanding and
Unvested
Restricted Stock
Awards ($)
(3)(4)
Plus: Change in
Fair Value of
Restricted Stock
Awards Granted
in Prior Years
that Vested in
During the Year
($)
(3)(4)
PEO – Thomas P. Mullin
2025
3,042,527 1,425,000 1,485,000 (466,668) (314,000) 2,321,859
PEO – David S. Chernow
2025
6,542,405 3,562,500 3,712,500 (630,668) (729,414) 5,332,323
2024
10,311,733 6,525,100 5,743,094 (774,997) 5,891,823 14,646,553
2023
10,706,265 7,480,000 5,875,000 (487,666) 1,724,170 10,337,769
2022
8,780,479 7,427,500 6,207,500 (2,056,500) 55,000 5,558,979
2021
11,687,600 7,932,000 5,880,000 870,000 2,947,500 13,453,100
Non-PEO NEOs
2025
4,061,009 2,048,438 2,134,688 (452,334) (391,116) 3,303,809
2024
6,334,427 3,851,228 3,389,674 (484,376) 2,906,742 8,295,239
2023
6,052,815 4,002,400 3,172,500 (272,207) 887,688 5,838,396
2022
5,868,199 4,827,875 4,034,875 (1,336,725) 35,750 3,774,224
2021
7,846,358 5,155,800 3,822,000 565,500 1,915,875 8,993,933
(1)
The PEOs were David Chernow and Thomas Mullin for 2025. The non-PEO NEOs were Robert Ortenzio, Michael Malatesta, Martin Jackson, and John Saich for 2025. The PEO was David Chernow for 2024, 2023, 2022, and 2021. The non-PEO NEOs were Robert Ortenzio, Michael Malatesta, Martin Jackson, and Thomas Mullin for 2024. The non-PEO NEOs were Robert Ortenzio, Rocco Ortenzio, Martin Jackson, Michael Malatesta, and Michael Tarvin for 2023. The non-PEO NEOs were Robert Ortenzio, Rocco Ortenzio, Martin Jackson and Michael Tarvin for 2022 and 2021.
(2)
Represents the grant date fair value of restricted stock awards as reported in the “Stock Awards” column of the Summary Compensation Table for each applicable year.
(3)
Adjustments are equal to (i) the year-end fair value of restricted stock awards granted during the applicable year that are outstanding and unvested as of the end of the year, (ii) the amount of the change in fair value as of the end of the applicable year (from the end of the prior fiscal year) of any restricted stock awards granted in prior years that are outstanding and unvested as of the end of the applicable year, and (iii) for restricted stock awards granted in prior years that vest in the applicable year, an amount equal to the change in fair value as of the vesting date (from the end of the prior fiscal year).
(4)
Restricted stock awards are valued using the market price of our stock. The closing market price of our stock was $14.85, $18.85, $23.50, $24.83, and $29.40 as of December 31, 2025, 2024, 2023, 2022, and 2021, respectively. The closing market price of our stock was $18.24 on April 30, 2025, when the annual vesting of Messrs. Chernow’s, Robert A. Ortenzio’s, and Jackson’s April 30, 2024 restricted stock awards occurred. The closing market price of our stock was $12.57 on August 1, 2025, when the annual vesting of Messrs. Chernow’s, Robert A. Ortenzio’s, and Jackson’s August 1, 2022 and 2023 restricted stock awards occurred, and when Messrs. Mullin’s and Saich’s August 1, 2022 restricted stock awards vested. The closing market price of our stock was $13.83 on November 1, 2025, when the vesting of Mr. Malatesta’s November 1, 2021 restricted stock awards occurred.
The closing market price of our stock was $39.18 on August 1, 2024, when the annual vesting of Messrs. Chernow’s, Robert A. Ortenzio’s, and Jackson’s August 1, 2022 and 2023 restricted stock awards occurred. The closing market price of our stock was $34.18 on August 3, 2024, when Messrs. Chernow’s, Robert A. Ortenzio’s, and Jackson’s August 3, 2021 restricted stock awards vested. The closing market price was $31.74 on October 27, 2024 when Messrs. Malatesta’s and Mullin’s October 27, 2020 restricted stock
awards vested. The closing market price of our stock was $37.21 on November 5, 2024 , when Messrs. Chernow’s, Robert A. Ortenzio’s, Malatesta’s, Jackson’s, and Tarvin’s accelerated vesting on all unvested outstanding restricted stock awards occurred, as discussed above.
The closing market price of our stock was $30.03 on July 28, 2023, when Messrs. Chernow, Robert A. Ortenzio, Rocco A. Ortenzio, Jackson and Tarvin’s July 28, 2020 restricted stock awards vested. The closing market price of our stock was $29.92 on August 1, 2023, when the annual vesting of their August 1, 2022 restricted stock awards occurred. The closing market price of our stock was 22.61 on October 29, 2023, when Mr. Malatesta’s October 29, 2019 restricted stock awards vested.
The closing market price of our stock was $29.62 on July 30, 2022, when Messrs. Chernow, Robert A. Ortenzio, Rocco A. Ortenzio, Jackson, and Tarvin’s July 30, 2019 restricted stock awards vested.
The closing market price of our stock was $39.45 on July 30, 2021, when Messrs. Chernow, Robert A. Ortenzio, Rocco A. Ortenzio, Jackson, and Tarvin’s July 30, 2018 restricted stock awards vested.
                               
Company Selected Measure Name EPS                                
Named Executive Officers, Footnote
(1)
The PEOs were David Chernow and Thomas Mullin for 2025. The non-PEO NEOs were Robert Ortenzio, Michael Malatesta, Martin Jackson, and John Saich for 2025. The PEO was David Chernow for 2024, 2023, 2022, and 2021. The non-PEO NEOs were Robert Ortenzio, Michael Malatesta, Martin Jackson, and Thomas Mullin for 2024. The non-PEO NEOs were Robert Ortenzio, Rocco Ortenzio, Martin Jackson, Michael Malatesta, and Michael Tarvin for 2023. The non-PEO NEOs were Robert Ortenzio, Rocco Ortenzio, Martin Jackson and Michael Tarvin for 2022 and 2021.
                               
Adjustment To PEO Compensation, Footnote
The following table outlines the adjustments made to the compensation earned by the Company’s PEOs and other NEOs, as presented in the Summary Compensation Table on page 22, to derive the compensation actually paid to the Company’s PEOs and other NEOs.
Year(1)
Summary
Compensation
Table Total
($)
Adjustments
Compensation
Actually Paid
($)
Less: Reported
Value of
Stock Awards
($)
(2)
Plus: Year End
Fair Value of
Restricted Stock
Awards Granted
During the Year
($)
(3)(4)
Plus: Change in
Fair Value of
Outstanding and
Unvested
Restricted Stock
Awards ($)
(3)(4)
Plus: Change in
Fair Value of
Restricted Stock
Awards Granted
in Prior Years
that Vested in
During the Year
($)
(3)(4)
PEO – Thomas P. Mullin
2025
3,042,527 1,425,000 1,485,000 (466,668) (314,000) 2,321,859
PEO – David S. Chernow
2025
6,542,405 3,562,500 3,712,500 (630,668) (729,414) 5,332,323
2024
10,311,733 6,525,100 5,743,094 (774,997) 5,891,823 14,646,553
2023
10,706,265 7,480,000 5,875,000 (487,666) 1,724,170 10,337,769
2022
8,780,479 7,427,500 6,207,500 (2,056,500) 55,000 5,558,979
2021
11,687,600 7,932,000 5,880,000 870,000 2,947,500 13,453,100
Non-PEO NEOs
2025
4,061,009 2,048,438 2,134,688 (452,334) (391,116) 3,303,809
2024
6,334,427 3,851,228 3,389,674 (484,376) 2,906,742 8,295,239
2023
6,052,815 4,002,400 3,172,500 (272,207) 887,688 5,838,396
2022
5,868,199 4,827,875 4,034,875 (1,336,725) 35,750 3,774,224
2021
7,846,358 5,155,800 3,822,000 565,500 1,915,875 8,993,933
(1)
The PEOs were David Chernow and Thomas Mullin for 2025. The non-PEO NEOs were Robert Ortenzio, Michael Malatesta, Martin Jackson, and John Saich for 2025. The PEO was David Chernow for 2024, 2023, 2022, and 2021. The non-PEO NEOs were Robert Ortenzio, Michael Malatesta, Martin Jackson, and Thomas Mullin for 2024. The non-PEO NEOs were Robert Ortenzio, Rocco Ortenzio, Martin Jackson, Michael Malatesta, and Michael Tarvin for 2023. The non-PEO NEOs were Robert Ortenzio, Rocco Ortenzio, Martin Jackson and Michael Tarvin for 2022 and 2021.
(2)
Represents the grant date fair value of restricted stock awards as reported in the “Stock Awards” column of the Summary Compensation Table for each applicable year.
(3)
Adjustments are equal to (i) the year-end fair value of restricted stock awards granted during the applicable year that are outstanding and unvested as of the end of the year, (ii) the amount of the change in fair value as of the end of the applicable year (from the end of the prior fiscal year) of any restricted stock awards granted in prior years that are outstanding and unvested as of the end of the applicable year, and (iii) for restricted stock awards granted in prior years that vest in the applicable year, an amount equal to the change in fair value as of the vesting date (from the end of the prior fiscal year).
(4)
Restricted stock awards are valued using the market price of our stock. The closing market price of our stock was $14.85, $18.85, $23.50, $24.83, and $29.40 as of December 31, 2025, 2024, 2023, 2022, and 2021, respectively. The closing market price of our stock was $18.24 on April 30, 2025, when the annual vesting of Messrs. Chernow’s, Robert A. Ortenzio’s, and Jackson’s April 30, 2024 restricted stock awards occurred. The closing market price of our stock was $12.57 on August 1, 2025, when the annual vesting of Messrs. Chernow’s, Robert A. Ortenzio’s, and Jackson’s August 1, 2022 and 2023 restricted stock awards occurred, and when Messrs. Mullin’s and Saich’s August 1, 2022 restricted stock awards vested. The closing market price of our stock was $13.83 on November 1, 2025, when the vesting of Mr. Malatesta’s November 1, 2021 restricted stock awards occurred.
The closing market price of our stock was $39.18 on August 1, 2024, when the annual vesting of Messrs. Chernow’s, Robert A. Ortenzio’s, and Jackson’s August 1, 2022 and 2023 restricted stock awards occurred. The closing market price of our stock was $34.18 on August 3, 2024, when Messrs. Chernow’s, Robert A. Ortenzio’s, and Jackson’s August 3, 2021 restricted stock awards vested. The closing market price was $31.74 on October 27, 2024 when Messrs. Malatesta’s and Mullin’s October 27, 2020 restricted stock
awards vested. The closing market price of our stock was $37.21 on November 5, 2024 , when Messrs. Chernow’s, Robert A. Ortenzio’s, Malatesta’s, Jackson’s, and Tarvin’s accelerated vesting on all unvested outstanding restricted stock awards occurred, as discussed above.
The closing market price of our stock was $30.03 on July 28, 2023, when Messrs. Chernow, Robert A. Ortenzio, Rocco A. Ortenzio, Jackson and Tarvin’s July 28, 2020 restricted stock awards vested. The closing market price of our stock was $29.92 on August 1, 2023, when the annual vesting of their August 1, 2022 restricted stock awards occurred. The closing market price of our stock was 22.61 on October 29, 2023, when Mr. Malatesta’s October 29, 2019 restricted stock awards vested.
The closing market price of our stock was $29.62 on July 30, 2022, when Messrs. Chernow, Robert A. Ortenzio, Rocco A. Ortenzio, Jackson, and Tarvin’s July 30, 2019 restricted stock awards vested.
The closing market price of our stock was $39.45 on July 30, 2021, when Messrs. Chernow, Robert A. Ortenzio, Rocco A. Ortenzio, Jackson, and Tarvin’s July 30, 2018 restricted stock awards vested.
                               
Non-PEO NEO Average Total Compensation Amount $ 4,061,009 $ 6,334,427 $ 6,052,815 $ 5,868,199 $ 7,846,358                        
Non-PEO NEO Average Compensation Actually Paid Amount $ 3,303,809 8,295,239 5,838,396 3,774,224 8,993,933                        
Adjustment to Non-PEO NEO Compensation Footnote
The following table outlines the adjustments made to the compensation earned by the Company’s PEOs and other NEOs, as presented in the Summary Compensation Table on page 22, to derive the compensation actually paid to the Company’s PEOs and other NEOs.
Year(1)
Summary
Compensation
Table Total
($)
Adjustments
Compensation
Actually Paid
($)
Less: Reported
Value of
Stock Awards
($)
(2)
Plus: Year End
Fair Value of
Restricted Stock
Awards Granted
During the Year
($)
(3)(4)
Plus: Change in
Fair Value of
Outstanding and
Unvested
Restricted Stock
Awards ($)
(3)(4)
Plus: Change in
Fair Value of
Restricted Stock
Awards Granted
in Prior Years
that Vested in
During the Year
($)
(3)(4)
PEO – Thomas P. Mullin
2025
3,042,527 1,425,000 1,485,000 (466,668) (314,000) 2,321,859
PEO – David S. Chernow
2025
6,542,405 3,562,500 3,712,500 (630,668) (729,414) 5,332,323
2024
10,311,733 6,525,100 5,743,094 (774,997) 5,891,823 14,646,553
2023
10,706,265 7,480,000 5,875,000 (487,666) 1,724,170 10,337,769
2022
8,780,479 7,427,500 6,207,500 (2,056,500) 55,000 5,558,979
2021
11,687,600 7,932,000 5,880,000 870,000 2,947,500 13,453,100
Non-PEO NEOs
2025
4,061,009 2,048,438 2,134,688 (452,334) (391,116) 3,303,809
2024
6,334,427 3,851,228 3,389,674 (484,376) 2,906,742 8,295,239
2023
6,052,815 4,002,400 3,172,500 (272,207) 887,688 5,838,396
2022
5,868,199 4,827,875 4,034,875 (1,336,725) 35,750 3,774,224
2021
7,846,358 5,155,800 3,822,000 565,500 1,915,875 8,993,933
(1)
The PEOs were David Chernow and Thomas Mullin for 2025. The non-PEO NEOs were Robert Ortenzio, Michael Malatesta, Martin Jackson, and John Saich for 2025. The PEO was David Chernow for 2024, 2023, 2022, and 2021. The non-PEO NEOs were Robert Ortenzio, Michael Malatesta, Martin Jackson, and Thomas Mullin for 2024. The non-PEO NEOs were Robert Ortenzio, Rocco Ortenzio, Martin Jackson, Michael Malatesta, and Michael Tarvin for 2023. The non-PEO NEOs were Robert Ortenzio, Rocco Ortenzio, Martin Jackson and Michael Tarvin for 2022 and 2021.
(2)
Represents the grant date fair value of restricted stock awards as reported in the “Stock Awards” column of the Summary Compensation Table for each applicable year.
(3)
Adjustments are equal to (i) the year-end fair value of restricted stock awards granted during the applicable year that are outstanding and unvested as of the end of the year, (ii) the amount of the change in fair value as of the end of the applicable year (from the end of the prior fiscal year) of any restricted stock awards granted in prior years that are outstanding and unvested as of the end of the applicable year, and (iii) for restricted stock awards granted in prior years that vest in the applicable year, an amount equal to the change in fair value as of the vesting date (from the end of the prior fiscal year).
(4)
Restricted stock awards are valued using the market price of our stock. The closing market price of our stock was $14.85, $18.85, $23.50, $24.83, and $29.40 as of December 31, 2025, 2024, 2023, 2022, and 2021, respectively. The closing market price of our stock was $18.24 on April 30, 2025, when the annual vesting of Messrs. Chernow’s, Robert A. Ortenzio’s, and Jackson’s April 30, 2024 restricted stock awards occurred. The closing market price of our stock was $12.57 on August 1, 2025, when the annual vesting of Messrs. Chernow’s, Robert A. Ortenzio’s, and Jackson’s August 1, 2022 and 2023 restricted stock awards occurred, and when Messrs. Mullin’s and Saich’s August 1, 2022 restricted stock awards vested. The closing market price of our stock was $13.83 on November 1, 2025, when the vesting of Mr. Malatesta’s November 1, 2021 restricted stock awards occurred.
The closing market price of our stock was $39.18 on August 1, 2024, when the annual vesting of Messrs. Chernow’s, Robert A. Ortenzio’s, and Jackson’s August 1, 2022 and 2023 restricted stock awards occurred. The closing market price of our stock was $34.18 on August 3, 2024, when Messrs. Chernow’s, Robert A. Ortenzio’s, and Jackson’s August 3, 2021 restricted stock awards vested. The closing market price was $31.74 on October 27, 2024 when Messrs. Malatesta’s and Mullin’s October 27, 2020 restricted stock
awards vested. The closing market price of our stock was $37.21 on November 5, 2024 , when Messrs. Chernow’s, Robert A. Ortenzio’s, Malatesta’s, Jackson’s, and Tarvin’s accelerated vesting on all unvested outstanding restricted stock awards occurred, as discussed above.
The closing market price of our stock was $30.03 on July 28, 2023, when Messrs. Chernow, Robert A. Ortenzio, Rocco A. Ortenzio, Jackson and Tarvin’s July 28, 2020 restricted stock awards vested. The closing market price of our stock was $29.92 on August 1, 2023, when the annual vesting of their August 1, 2022 restricted stock awards occurred. The closing market price of our stock was 22.61 on October 29, 2023, when Mr. Malatesta’s October 29, 2019 restricted stock awards vested.
The closing market price of our stock was $29.62 on July 30, 2022, when Messrs. Chernow, Robert A. Ortenzio, Rocco A. Ortenzio, Jackson, and Tarvin’s July 30, 2019 restricted stock awards vested.
The closing market price of our stock was $39.45 on July 30, 2021, when Messrs. Chernow, Robert A. Ortenzio, Rocco A. Ortenzio, Jackson, and Tarvin’s July 30, 2018 restricted stock awards vested.
                               
Compensation Actually Paid vs. Total Shareholder Return
Relationship between Pay and TSR
[MISSING IMAGE: bc_totalsharereturn-bw.jpg]
                               
Compensation Actually Paid vs. Net Income
Relationship between Pay and Net Income
[MISSING IMAGE: bc_netincome-bw.jpg]
                               
Compensation Actually Paid vs. Company Selected Measure
Relationship between Pay and Earnings per Share
[MISSING IMAGE: bc_earningspershare-bw.jpg]
                               
Total Shareholder Return Vs Peer Group [MISSING IMAGE: bc_totalsharereturn-bw.jpg]                                
Tabular List, Table
For the year ended December 31, 2025, the most important financial performance measures used by the Company to link executive compensation actually paid to the Company’s financial performance were as follows:
i.
Earnings per share, and
ii.
Return on equity.
                               
Total Shareholder Return Amount $ 114.38 142.8 93.35 95.17 108.51                        
Peer Group Total Shareholder Return Amount 109.97 92.81 91.5 87.48 109.45                        
Net Income (Loss) $ 214,530,000 $ 296,700,000 $ 299,730,000 $ 198,030,000.00 $ 499,950,000                        
Company Selected Measure Amount | $ / shares 1.16 1.66 1.91 1.23 2.98                        
PEO Name David Chernow and Thomas Mullin                                
Share Price | $ / shares $ 14.85 $ 18.85 $ 23.5 $ 24.83 $ 29.4 $ 13.83 $ 12.57 $ 18.24 $ 37.21 $ 31.74 $ 34.18 $ 39.18 $ 22.61 $ 29.92 $ 30.03 $ 29.62 $ 39.45
Measure:: 1                                  
Pay vs Performance Disclosure                                  
Name Earnings per share                                
Measure:: 2                                  
Pay vs Performance Disclosure                                  
Name Return on equity                                
David S. Chernow [Member]                                  
Pay vs Performance Disclosure                                  
PEO Total Compensation Amount $ 6,542,405 $ 10,311,733 $ 10,706,265 $ 8,780,479 $ 11,687,600                        
PEO Actually Paid Compensation Amount 5,332,323 14,646,553 10,337,769 5,558,979 13,453,100                        
Thomas P. Mullin [Member]                                  
Pay vs Performance Disclosure                                  
PEO Total Compensation Amount 3,042,527                        
PEO Actually Paid Compensation Amount 2,321,859                        
PEO | David S. Chernow [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table                                  
Pay vs Performance Disclosure                                  
Adjustment to Compensation, Amount (3,562,500) (6,525,100) (7,480,000) (7,427,500) (7,932,000)                        
PEO | David S. Chernow [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested                                  
Pay vs Performance Disclosure                                  
Adjustment to Compensation, Amount 3,712,500 5,743,094 5,875,000 6,207,500 5,880,000                        
PEO | David S. Chernow [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested                                  
Pay vs Performance Disclosure                                  
Adjustment to Compensation, Amount (630,668) (774,997) (487,666) (2,056,500) 870,000                        
PEO | David S. Chernow [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year                                  
Pay vs Performance Disclosure                                  
Adjustment to Compensation, Amount (729,414) 5,891,823 1,724,170 55,000 2,947,500                        
PEO | Thomas P. Mullin [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table                                  
Pay vs Performance Disclosure                                  
Adjustment to Compensation, Amount (1,425,000)                                
PEO | Thomas P. Mullin [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested                                  
Pay vs Performance Disclosure                                  
Adjustment to Compensation, Amount 1,485,000                                
PEO | Thomas P. Mullin [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested                                  
Pay vs Performance Disclosure                                  
Adjustment to Compensation, Amount (466,668)                                
PEO | Thomas P. Mullin [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year                                  
Pay vs Performance Disclosure                                  
Adjustment to Compensation, Amount (314,000)                                
Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table                                  
Pay vs Performance Disclosure                                  
Adjustment to Compensation, Amount (2,048,438) (3,851,228) (4,002,400) (4,827,875) (5,155,800)                        
Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested                                  
Pay vs Performance Disclosure                                  
Adjustment to Compensation, Amount 2,134,688 3,389,674 3,172,500 4,034,875 3,822,000                        
Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested                                  
Pay vs Performance Disclosure                                  
Adjustment to Compensation, Amount (452,334) (484,376) (272,207) (1,336,725) 565,500                        
Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year                                  
Pay vs Performance Disclosure                                  
Adjustment to Compensation, Amount $ (391,116) $ 2,906,742 $ 887,688 $ 35,750 $ 1,915,875